Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/18 → 31/08/22 |
Funding
- NHMRC - National Health and Medical Research Council (Australia): A$476,535.00
-
Aryl bismuth phosphinates [BiAr2(O(O)PRR′)]: structure-activity relationships for antibacterial activity and cytotoxicity
Herdman, M. E., Werrett, M. V. & Andrews, P. C., 28 Jun 2022, In: Dalton Transactions. 51, 24, p. 9323-9335 13 p.Research output: Contribution to journal › Article › Research › peer-review
8 Link opens in a new tab Citations (Scopus) -
Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles
Griffith, D. M., Li, H., Werrett, M. V., Andrews, P. C. & Sun, H., 7 Nov 2021, In: Chemical Society Reviews. 50, 21, p. 12037-12069 33 p.Research output: Contribution to journal › Review Article › Research › peer-review
185 Link opens in a new tab Citations (Scopus) -
Bismuth(III) Thiophosphinates: Understanding How a Small Atomic Change Influences Antibacterial Activity and Mammalian Cell Viability
Senevirathna, D. C., Duffin, R. N., Stephens, L. J., Herdman, M. E., Werrett, M. V. & Andrews, P. C., 18 Sept 2020, In: Australian Journal of Chemistry. 73, 12, p. 1226-1236 11 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access3 Link opens in a new tab Citations (Scopus)
Equipment
-
Monash Centre for Electron Microscopy (MCEM)
Sorrell, F. (Manager) & Miller, P. (Manager)
Office of the Vice-Provost (Research and Research Infrastructure)Facility/equipment: Facility
-
Monash X-ray Platform (MXP)
Ma, J. S. (Manager)
Materials Science & EngineeringFacility/equipment: Facility